Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06619912
PHASE3

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Sponsor: Xijing Hospital

View on ClinicalTrials.gov

Summary

Delirium is a common consequence of cardiac surgery and associates with poor outcomes. Multiple causes can trigger delirium occurence, and it has been hypothesised that sleep disturbances can be one of them. Dexmedetomidine may be effective in reducing delirium. The aim of this study was to demonstrate preoperative dexmedetomidine nasal spray in cardiac surgery patients can reduce postoperative delirium by improving preoperative sleep.

Official title: Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients:a Single-center, Double- Blind, Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

686

Start Date

2025-03-03

Completion Date

2027-03-30

Last Updated

2025-07-22

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine nasal spray

Participants will be randomised to receive either dexmedetomidine or saline nasal spray (1.5ug/kg, ideal body weight) at the night before surgery and 30 minutes before induction.

Locations (1)

Xijing Hospital

Xi'an, Shaanxi, China